Suppr超能文献

使用昂丹司琼预防术后恶心和呕吐的给药时机。

Timing of ondansetron administration to prevent postoperative nausea and vomiting.

作者信息

Cruz Norma I, Portilla Peter, Vela Rosendo E

机构信息

Division of Plastic Surgery, Department of Surgery, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.

出版信息

P R Health Sci J. 2008 Mar;27(1):43-7.

Abstract

BACKGROUND

The original guidelines for using ondansetron recommending its administration prior to induction of anesthesia have been questioned.

METHOD

In an effort to determine the most effective timing of ondansetron administration to prevent postoperative nausea and vomiting (PONV), a prospective, randomized, double-blind study was performed. Patients undergoing ambulatory plastic surgery procedures estimated to last two hours or more and who had at least two risk factors for PONV (female gender, non-smoker, previous history of PONV and postoperative opioids) participated in the study. General anesthesia for all patients followed the same standard institutional protocol and all patients received dexamethasone 4 mg intravenously at the start of surgery. The control group (n = 188) received 4 mg of ondansetron intravenously prior to the induction of anesthesia. The study group (n = 184) received 4 mg of ondansetron intravenously 30 minutes prior to completion of the surgery. The incidence of PONV during the early (0-2 hours) and delayed (2-24 hours) postoperative periods was recorded.

RESULTS

No significant difference was found between the groups regarding early postoperative nausea or vomiting (p > 0.05). However, a significant difference (p < 0.05) was noted in both late postoperative nausea (control: 30% vs. study group: 20%) and late postoperative vomiting (control: 17% vs. study group: 8%).

CONCLUSION

This clinical study indicates that when performing prolonged surgical procedures, late administration of ondansetron (within 30 minutes prior to completing the surgery) is significantly more effective in the prevention of late PONV than when administered prior to the induction of anesthesia.

摘要

背景

使用昂丹司琼的原始指南建议在麻醉诱导前给药,这一建议受到了质疑。

方法

为了确定昂丹司琼预防术后恶心和呕吐(PONV)的最有效给药时间,进行了一项前瞻性、随机、双盲研究。预计持续两小时或更长时间的门诊整形手术患者,且至少有两个PONV风险因素(女性、不吸烟、PONV既往史和术后使用阿片类药物)参与了该研究。所有患者的全身麻醉均遵循相同的标准机构方案,所有患者在手术开始时静脉注射4毫克地塞米松。对照组(n = 188)在麻醉诱导前静脉注射4毫克昂丹司琼。研究组(n = 184)在手术结束前30分钟静脉注射4毫克昂丹司琼。记录术后早期(0 - 2小时)和延迟期(2 - 24小时)PONV的发生率。

结果

两组在术后早期恶心或呕吐方面无显著差异(p > 0.05)。然而,在术后晚期恶心(对照组:30% vs. 研究组:20%)和术后晚期呕吐(对照组:17% vs. 研究组:8%)方面均存在显著差异(p < 0.05)。

结论

这项临床研究表明,在进行长时间外科手术时,昂丹司琼延迟给药(在手术结束前30分钟内)在预防晚期PONV方面比在麻醉诱导前给药显著更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验